NFE2L2 and cancer: Constitutive NRF2 activation promotes cancer initiation by conferring keratinocyte survival advantage (such as antiapoptosis) in adverse conditions [38, 49], as well as protumorigenic metabolic reprogramming toward anabolic glucose metabolism via the pentose phosphate pathway [46, 48].